Patents by Inventor Lane K. Law

Lane K. Law has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Adenovirus serotype 30 (Ad30)
    Patent number: 7410954
    Abstract: The present invention provides an adenovirus serotype 30 (Ad30) fiber amino acid sequence. The present invention also provides polynucleotides and expression vectors encoding an Ad30 fiber and viral particles and cells containing such expression vectors. The present invention further provides methods of treating genetic diseases or cancers in a mammal using the polynucleotides, polypeptides, expression vectors, viral particles and cells of the present invention.
    Type: Grant
    Filed: July 15, 2003
    Date of Patent: August 12, 2008
    Assignee: University of Iowa Research Foundation
    Inventors: Beverly L. Davidson, Lane K. Law
  • Adenovirus serotype 30 (Ad30)
    Publication number: 20040038924
    Abstract: The present invention provides an adenovirus serotype 30 (Ad30) fiber amino acid sequence. The present invention also provides polynucleotides and expression vectors encoding an Ad30 fiber and viral particles and cells containing such expression vectors. The present invention further provides methods of treating genetic diseases or cancers in a mammal using the polynucleotides, polypeptides, expression vectors, viral particles and cells of the present invention.
    Type: Application
    Filed: July 15, 2003
    Publication date: February 26, 2004
    Applicant: University of Iowa Research Foundation
    Inventors: Beverly L. Davidson, Lane K. Law
  • Adenovirus serotype 30 (Ad30)
    Patent number: 6635466
    Abstract: The present invention provides an adenovirus serotype 30 (Ad30) fiber amino acid sequence. The present invention also provides polynucleotides and expression vectors encoding an Ad30 fiber and viral particles and cells containing such expression vectors. The present invention further provides methods of treating genetic diseases or cancers in a mammal using the polynucleotides, polypeptides, expression vectors, viral particles and cells of the present invention.
    Type: Grant
    Filed: January 9, 2001
    Date of Patent: October 21, 2003
    Assignee: University of Iowa Research Foundation
    Inventors: Beverly L. Davidson, Lane K. Law
  • Receptor-targeted adenoviral vectors
    Publication number: 20030133912
    Abstract: The invention provides adenoviral vectors possessing fibers that do not bind CAR, a receptor-targeting ligand sequence, the non-receptor targeting sequence derived from HIV-TAT, a sequence encoding the HI loop of the non-CAR binding adenovirus fiber, which permits specific receptor-targeted transduction with the recombinant adenovirus vectors. The invention also provides related chimeric proteins, adenovirus particles and mammalian cells.
    Type: Application
    Filed: November 7, 2002
    Publication date: July 17, 2003
    Inventors: Beverly L. Davidson, Haibin Xia, Lane K. Law
  • Adenovirus serotype 30 (Ad30)
    Publication number: 20020127721
    Abstract: The present invention provides an adenovirus serotype 30 (Ad30) fiber amino acid sequence. The present invention also provides polynucleotides and expression vectors encoding an Ad30 fiber and viral particles and cells containing such expression vectors. The present invention further provides methods of treating genetic diseases or cancers in a mammal using the polynucleotides, polypeptides, expression vectors, viral particles and cells of the present invention.
    Type: Application
    Filed: January 9, 2001
    Publication date: September 12, 2002
    Inventors: Beverly L. Davidson, Lane K. Law